10x Genomics (TXG) 股票今日为何上涨 - 雅虎财经
Why 10x Genomics (TXG) Stock Is Trading Up Today - Yahoo Finance
生物技术与制药领域的最新动态
Why 10x Genomics (TXG) Stock Is Trading Up Today - Yahoo Finance
Regulatory, cGMP, and CDMO Challenges: A CPHI Conversation with Lonza Capsugel, Part Two - PharmTech.com
Illumina: An Excellent Profit Margin And The Sequencing Genome Market Will Unlock Value - Seeking Alpha
Thermo Fisher Scientific Debuts Orbitrap Exploris EFOX Mass Detector - Food Engineering Mag
Thermo Fisher Unveils $5 Billion Buyback, Keeps Dividend Intact - Yahoo Finance
10X Genomics Tops Q3 Estimates And Cuts Losses - Finimize
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% - Markets Financial Content
10x Genomics Reports Third Quarter 2025 Financial Results - Barchart.com
10x Genomics Reports Third Quarter 2025 Financial Results - Eastern Progress
Targeted Protein Degradation: How Chemoproteomics and Induced Proximity Are Shaping Drug Discovery
Why Thermo Fisher Scientific Stock Jumped 40%? - Trefis
Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases - Business Wire
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates - Nasdaq
10X Genomics earnings beat by $0.07, revenue topped estimates - Investing.com
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics - Nasdaq
10x Genomics (NASDAQ: TXG) guides fourth‑quarter revenue to $154–$158M after results - Stock Titan
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% - Yahoo Finance
10x Genomics Reports Third Quarter 2025 Financial Results - PR Newswire